Clinical Trial Update: Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD

View source ↗

Summary

A clinical trial update indicates a study using Telo Genomics technology to detect and profile minimal residual disease in multiple myeloma is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Multiple Myeloma | Status: RECRUITING